Immunoreactive Creatine Kinase-MB and Creatine Kinase Isozyme Concentrations During Treatment of Hypothyroid Patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Erschienen in
-
In: Clinical Chemistry and Laboratory Medicine, Band 32, Ausgabe 8, Seite 589-594, 2009
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Humboldt-Universität zu Berlin
- (wann)
-
1994
- Urheber
-
Miyamoto, Takako
Nagasaka, Akio
Kato, Kanefusa
Masunaga, Rumi
Kotake, Motoko
Kawabe, Tetsuya
Nakai, Akira
Mokuno, Takehiko
Sawai, Yoshikuni
Oda, Naohisa
Mano, Toshiki
Nishida, Yuko
- DOI
-
10.18452/9917
- URN
-
urn:nbn:de:kobv:11-100119420
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Miyamoto, Takako
- Nagasaka, Akio
- Kato, Kanefusa
- Masunaga, Rumi
- Kotake, Motoko
- Kawabe, Tetsuya
- Nakai, Akira
- Mokuno, Takehiko
- Sawai, Yoshikuni
- Oda, Naohisa
- Mano, Toshiki
- Nishida, Yuko
- Humboldt-Universität zu Berlin
Entstanden
- 1994
Ähnliche Objekte (12)
Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Therapeutic targeting of MAP kinase kinase 4 for the treatment of liver diseases
The Mass Concentrations of Serum Troponin T and Creatine Kinase-MB are Elevated before Creatine Kinase and Creatine Kinase-MB Activities in Acute Myocardial Infarction
Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment
Macro-Creatine Kinase-BB: Observations on 6 Patients
Photoswitchable Kinase Inhibitors to Reversibly Control Kinase Activity
Quantitative Determination of Creatine Kinase Isoenzyme Catalytic Concentrations in Serum Using Immunological Methods
Identification and characterization of kinase-sparing aurora kinase A ligands for treatment of TP53-altered liver carcinomas
The Isoelectric Focusing of Creatine Kinase Variants: II. The Heterogeneity of Creatine Kinase in Human Serum with Normal and Elevated Catalytic Concentrations
Protein kinase C
Therapeutic kinase inhibitors
Photoactivatable Kinase Inhibitors
Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Therapeutic targeting of MAP kinase kinase 4 for the treatment of liver diseases
The Mass Concentrations of Serum Troponin T and Creatine Kinase-MB are Elevated before Creatine Kinase and Creatine Kinase-MB Activities in Acute Myocardial Infarction
Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment
Macro-Creatine Kinase-BB: Observations on 6 Patients
Photoswitchable Kinase Inhibitors to Reversibly Control Kinase Activity
Quantitative Determination of Creatine Kinase Isoenzyme Catalytic Concentrations in Serum Using Immunological Methods
Identification and characterization of kinase-sparing aurora kinase A ligands for treatment of TP53-altered liver carcinomas
The Isoelectric Focusing of Creatine Kinase Variants: II. The Heterogeneity of Creatine Kinase in Human Serum with Normal and Elevated Catalytic Concentrations
Protein kinase C
Therapeutic kinase inhibitors
Photoactivatable Kinase Inhibitors
Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Therapeutic targeting of MAP kinase kinase 4 for the treatment of liver diseases
The Mass Concentrations of Serum Troponin T and Creatine Kinase-MB are Elevated before Creatine Kinase and Creatine Kinase-MB Activities in Acute Myocardial Infarction
Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment
Macro-Creatine Kinase-BB: Observations on 6 Patients
Photoswitchable Kinase Inhibitors to Reversibly Control Kinase Activity
Quantitative Determination of Creatine Kinase Isoenzyme Catalytic Concentrations in Serum Using Immunological Methods
Identification and characterization of kinase-sparing aurora kinase A ligands for treatment of TP53-altered liver carcinomas
The Isoelectric Focusing of Creatine Kinase Variants: II. The Heterogeneity of Creatine Kinase in Human Serum with Normal and Elevated Catalytic Concentrations
Protein kinase C
Therapeutic kinase inhibitors